Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Brain Navi NaoTrac, the Brain Surgical Navigation Robot, Received European CE Mark Approval in 2021 2021-11-23 21:10
Inaugural Asia Summit on Global Health held 24 November in hybrid format in Hong Kong 2021-11-23 19:40
Bionomics Files Registration Statement for Proposed Initial Public Offering in the United States 2021-11-23 19:37
Seegene Announces Q3 2021 Earnings, Continuing COVID-Era Momentum 2021-11-23 16:03
PromarkerD distribution network expands to Britain 2021-11-23 11:56
Gilead Sciences, the Coalition to Eradicate Viral Hepatitis in Asia Pacific (CEVHAP), and the World Hepatitis Alliance (WHA) Collaborate to Support Elimination of Hepatitis by 2030 2021-11-23 11:00
EZZ accelerates genomic health focus with launch of two new biotic products 2021-11-23 04:00
Arctic Vision Announces First Patient Dosed in Phase III Study of ARVN001 for Treatment of Macular Edema Associated with Uveitis (UME) 2021-11-22 23:17
Getinge accelerates growth and productivity to reach new financial targets 2021-11-22 21:50
Ascentage Pharma's Olverembatinib Granted Orphan Designation by the European Commission for the Treatment of Chronic Myeloid Leukemia 2021-11-22 21:24
Alterity Therapeutics to Participate in Two Upcoming Investor Conferences 2021-11-22 20:50
CARsgen Receives CTA Authorization from Health Canada for CLDN18.2-targeted CAR T-cell Product CT041 2021-11-22 20:00
Baidu Enters Into License Agreement With Sanofi to Enable Next-Generation mRNA Therapeutics and Vaccines 2021-11-22 20:00
Breakthrough Chemotherapy Heart Protection Discovery for Australian Biotech 2021-11-22 09:24
DSM recognized for advancing sustainable food commitments and novel science-based solutions across Asia Pacific 2021-11-22 09:00
Innovent Announces Inclusion of the Company's Stock (01801.HK) in the Hang Seng China Enterprises Index 2021-11-22 08:00
CStone Pharmaceuticals and Jiangsu Hengrui Pharmaceuticals announce strategic partnership and exclusive licensing agreement on anti-CTLA-4 monoclonal antibody CS1002 in Greater China 2021-11-21 17:09
CStone Pharmaceuticals and Jiangsu Hengrui Pharmaceuticals announce strategic partnership and exclusive licensing agreement on anti-CTLA-4 monoclonal antibody CS1002 in Greater China 2021-11-21 17:02
US FDA Grants Breakthrough Designation for Early-Stage Breast Cancer Detection Blood Test Developed by Datar Cancer Genetics 2021-11-20 08:00
Kangtai Adenovirus Vector COVID-19 Vaccine (KCONECAVAC) Exported for the First Time 2021-11-19 18:52
1 196 197 198 199 200 440